Skip to content

Drug interactions

Brentuximab + Imatinib

Severity: Moderate

Brentuximab and Imatinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Imatinib inhibits CYP3A4 and may increase MMAE exposure from brentuximab vedotin. Both drugs can cause myelosuppression, so toxicity may be greater.

What this interaction means in plain words

Brentuximab and Imatinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Brentuximab belongs to Oncology; Imatinib belongs to Oncology.

Evidence level: Low

Why it happens

Moderate CYP3A4 inhibition reduces MMAE clearance, with additive myelosuppression.

What to do

Monitor blood counts and for neuropathy or infection during combined use; delay or reduce treatment if toxicity develops.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Brentuximab and Imatinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Brentuximab with Imatinib?

MediHelp rates the interaction as moderate. Brentuximab and Imatinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Imatinib inhibits CYP3A4 and may increase MMAE exposure from brentuximab vedotin. Both drugs can cause myelosuppression, so toxicity may be greater.

How serious is the interaction between Brentuximab and Imatinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood counts and for neuropathy or infection during combined use; delay or reduce treatment if toxicity develops.

What other medicines interact with Brentuximab?

MediHelp also lists interactions of Brentuximab with, for example, Bleomycin, Dengue vaccine, Etrasimod. The full list is on the Brentuximab page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in